Automated Insulin Delivery for Type 1 Diabetes

Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.

Who Is on the Research Team?

DM

David Maahs, MD, PhD

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

Inclusion Criteria

I was diagnosed with type 1 diabetes in the last 2 weeks.
* intent to follow at Stanford Children's Pediatric Diabetes Clinic for clinical care

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants initiate early use of an automated insulin delivery system using either Tandem Mobi or Tandem X2 for approximately 2 months

8 weeks
Regular visits for device monitoring and insulin dose adjustments

Follow-up

Participants are monitored for sustained use of the AID system and glycemic outcomes

1 year
Periodic follow-up visits to assess long-term use and outcomes

What Are the Treatments Tested in This Trial?

Interventions

  • Tandem Automated Insulin Delivery System

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Tandem Insulin PumpExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+